Alyeska Investment Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$2.54M	–	538
2022 Q4	$2.54M	Buy	+100,000	New	+$2.33M	0.03%	304
2018 Q3	–	Sell	-338,789	Closed	-$2.38M	–	504
2018 Q2	$2.38M	Buy	338,789 +10,834	+3%	+$106K	0.02%	340
2018 Q1	$4.67M	Sell	327,955 -2,955	-0.9%	-$31.4K	0.04%	296
2017 Q4	$2.9M	Hold	330,910	–	–	0.02%	302
2017 Q3	$3.87M	Buy	330,910 +5,910	+2%	+$72.4K	0.03%	311
2017 Q2	$4.54M	Buy	325,000 +152,614	+89%	+$1.74M	0.04%	291
2017 Q1	$2.37M	Sell	172,386 -52,614	-23%	-$546K	0.02%	385
2016 Q4	$1.61M	Buy	225,000 +56,228	+33%	+$616K	0.01%	404
2016 Q3	$2.56M	Buy	168,772 +43,772	+35%	+$576K	0.02%	373
2016 Q2	$1.23M	Sell	125,000 -50,000	-29%	-$686K	0.01%	379
2016 Q1	$2.33M	Buy	+175,000	New	+$2.2M	0.02%	318